Since joining Hanson Wade in 2021, Isabella has been committed to producing high-quality events to accelerate knowledge sharing in the Cell Therapy space, applying her degree in Biological Sciences from Durham University. With responsibility for the Cell Type Portfolio, Isabella has focused on bringing together niche communities within the industry employing a range of cells including TIL, macrophages, Tregs, iPSCs, and TCR-Ts to progress next-generation therapies. Isabella now looks to apply her experience to produce the flagship CAR-TCR event series..